Take on MS

Some in the MS community may not know us yet, but Genentech has a long history of scientific achievements that goes back 40 years.

Science

is in our DNA.

The Genentech journey began with the unlikely meeting between a venture capitalist and a scientist, two men united by a shared passion for a seemingly crazy idea–that if we look inside, into the very fabric of our DNA, we might find a way to help people suffering from the world’s worst medical conditions.

And while we’ve succeeded in some areas, there is still so much to do. So we do the everyday work. We follow the science.

A history of

Firsts

Genentech is a member of the Roche Group, with headquarters in South San Francisco, California. We have about 14,000 full-time employees, including more than 1,200 scientists and researchers.
Learn more about us at gene.com.

Our

Commitment

We’ve been providing assistance to patients since our first medicine was approved in 1985. To date, we’ve helped more than 1.2 million patients access the medicines they need. In 2014 alone:

More than

180,000

patients were helped in accessing the Genentech medicines needed.

Approximately

25,000

patients who qualified were provided free medicine through the Genentech® Access to Care Foundation (GATCF).*

More than

80,000

patients received co-pay support through our donations to independent non-profit organizations.*

*In 2014. Patients must meet certain criteria.

Let’s

Stay in Touch

As we talk with more and more people, we’d like to share what we’re hearing with you through e-mails, at live events, and on social media. Sign up now to stay connected.

Sign Up